Transplants and Risk Adapted Maintenance in Myeloma Treatment
November 30, 2018
UPCOMING/Recent Talks

Transplants and Risk Adapted Maintenance in Myeloma Treatment

with Dr. Sagar Lonial
December 13, 2018, Noon EST RSVP
The treatment paradigm for myeloma patients has changed in the last decade with important advancements such as proteasome inhibitors, IMiDS, antibodies and risk-adapted maintenance. How a patient responds to therapy can be used to determine how long the maintenance or follow-up therapy should be. This is called risk-adapted therapy and personalizes myeloma care. The myeloma panel is talking to Dr. Sagar Lonial of Winship Cancer Institute of Emory University, to learn how he uses genetic and disease risk factors to personalize maintenance strategies after stem cell transplants for his patients with multiple myeloma.
Dr. Sagar Lonial 
Gary Petersen 
Jack Aiello 
Cynthia Chmielewski
Priya Menon
November 15th, 2018. 5 PM EST
Eat more and pile on weight. Eat less and loose weight. Or is it that simple? HOW and WHAT should we eat to stay fit and stay away from obesity? We talked to investigative science & health Journalist and co-founder of the non-profit Nutrition Science Initiative ( Gary Taubes, to discuss the relationship of Obesity with different kinds of Calories, the current state of nutrition research, and mull over some controversial concepts in nutrition science. Mr Gary Taubes is a recipient of the Robert Wood Johnson Foundation Investigator Award in Health Policy Research.

Gary Taubes 
Mary Kay Irving
Mindy Stone 
Suzanne Garrett
Shweta Mishra
November 13, 2018. 2 PM EST LISTEN
Of the nearly 100,000 people waiting for a kidney transplant in the U.S., many will never get one. Meanwhile, hundreds of Hepatitis C infected organs are discarded because of the infection. The doctors at University of Pennsylvania connected these events and led a study that successfully showed that it is possible to transplant Hepatitis C infected kidneys into a patient and treat the disease in the recipient thereby saving his life. This revolutionary treatment is good news for those in need of a transplant; particularly patients who are facing long wait times, often 7 to 10 years and spending much of their daily lives on dialysis. We talked to Dr David Goldberg and Dr Peter Reese from the University of Pennsylvania, who led the study, about their journey and how they are expanding this treatment process to transplant hearts and other organs.
Dr Peter Reese 
Dr David Goldberg
Kiran Shelat
Connie Welch
Priya Menon 
For any of the talks dial-in to 718-664-6574 to participate and ask a question LIVE On-Air! Only 50 callers permitted at one time so HURRY!
Our Picks
TrialX Editor